Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Quantum Materials is a U.S.-based nanotechnology company focused on designing and manufacturing quantum dots and other uniform nanoparticles using a patented continuous-flow production process. Its core business is materials science rather than therapeutics, with applications spanning solar, QR/barcode authentication, medical devices, and diagnostic technologies. The company has also pursued healthcare-adjacent programs through QMC HealthID and QMC Health, including quantum-dot-enhanced COVID-19 testing and a Long COVID rapid test concept. Quantum Materials appears to remain operating as an independent company and continues to market its scaled nanoparticle development and production capabilities from San Marcos, Texas. For biotech and healthcare diligence, it is best characterized as a diagnostics-enabling nanomaterials/platform company rather than a traditional biotech or pharma developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Quantum Materials.